Skip to content


  • Oral presentation
  • Open Access

The present situation of Rare Diseases in Central/Eastern Europe? The role of patient organisations

Orphanet Journal of Rare Diseases20105 (Suppl 1) :O30

  • Published:


  • Human Resource
  • Social Service
  • Rare Disease
  • Organisation Level
  • Important Observation

Our goal was to introduce the limited available comparative data to characterise the situation in Central/Eastern Europe in the field of rare diseases. We collected the most important observations of current international surveys which were performed with or without the involvement of member associations of EURORDIS.


1, At the level of medical and social services: It is still “incidental” to get to the appropriate expert or centre for diagnosis or treatment. It is difficult to find even the services, because of the lack of suitable “pathways” and referral. There are long delays in obtaining the first appointment, resulting in defencelessness and regional irregularity. The overall consequence is the lack of access to medical and to social services. We also have difficulties with the supply of orphan medication and with the long duration of hospitalisations.

2, At the level of patient organisations: financial scarcity and uncertainty is typical and combined with inappropriate infrastructural background and human resources.


We need to continue our efforts for the formation of Centres of Expertise and their Networks together with the development of our National Plans. We also want to improve habilitation and rehabilitation services to compensate the social disadvantages. The relative low organisation level of patient organisations and the unsatisfactory level of their cooperation is also characteristic. More effective, professional operations associated with strategic approaches, with the help of national and international cooperation is necessary!

Authors’ Affiliations

Hufferdis, Üllői út 82, Budapest, H-1082, Hungary


© Pogany; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.